Dr. Gleicher discusses cancer risks to IVF kids on Reuters

In a Reuters article, Dr. Gleicher explained the possible reason behind the elevated cancer risks in IVF offspring. Noting the extremely low absolute risk and risk-benefit analysis, Dr. Gleicher advised against foregoing IVF. Read the Reuters article here, and our recap here.

Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.